(Q40726594)

23 September 2017

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma (English)

1 reference

23 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

23 November 2023

author

Vanna Chiarion Sileni

8

object named as

V. Chiarion-Sileni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

author name string

L. Salvagno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

A. Contu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

A. Bianco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

L. Endrizzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

G. M. Schintu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

N. Olmeo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

S. M. Aversa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

M. Sorarù

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

M. V. Fiorentino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

23 November 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1286045

23 November 2023

publication date

1 December 1992

1 reference

full work available at URL

23 September 2017

https://academic.oup.com/annonc/article-pdf/3/10/833/303440/3-10-833.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

http://annonc.oxfordjournals.org/cgi/content/abstract/3/10/833

23 November 2023

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286045

https://api.elsevier.com/content/article/PII:S0923753419654165?httpAccept=text/xml

23 November 2023

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

https://api.elsevier.com/content/article/PII:S0923753419654165?httpAccept=text/plain

23 November 2023

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

http://academic.oup.com/annonc/article-pdf/3/10/833/303440/3-10-833.pdf

23 November 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

23 November 2023

1 reference

23 September 2017

3

1 reference

23 September 2017

10

1 reference

23 September 2017

833-837

1 reference

Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group study

23 September 2017

3

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

An EORTC phase II study of mitoxantrone in solid tumors and lymphomas

23 November 2023

5

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease

23 November 2023

6

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Etoposide as single agent and in combination with cis-platinum for malignant lymphomas

23 November 2023

8

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma

23 November 2023

9

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

23 November 2023

11

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Non-Hodgkin's lymphomas: a clinicopathologic study of 293 cases

23 November 2023

14

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

23 November 2023

17

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

23 November 2023

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma

23 November 2023

19

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma

23 November 2023

20

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen

23 November 2023

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Combination Chemotherapy Specifically Devised for Elderly Patients with Unfavorable Non-Hodgkin's Lymphoma

23 November 2023

23

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma

23 November 2023

24

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma

23 November 2023

25

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058106

23 November 2023

Identifiers

1 reference

23 September 2017

1 reference